Elif Yakisan

1.0k total citations
12 papers, 747 citations indexed

About

Elif Yakisan is a scholar working on Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Elif Yakisan has authored 12 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Elif Yakisan's work include Acute Lymphoblastic Leukemia research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Elif Yakisan is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Elif Yakisan collaborates with scholars based in Germany, United States and Ireland. Elif Yakisan's co-authors include Alfred Reiter, Martin Schrappe, Martin Zimmermann, Hansjörg Riehm, Bernhard Kremens, Markus Tiemann, Wolfgang Ludwig, Georg Mann, Reza Parwaresch and F Zintl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Pediatrics.

In The Last Decade

Elif Yakisan

12 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elif Yakisan Germany 11 391 254 229 176 146 12 747
Wolf‐Dieter Ludwig Germany 15 424 1.1× 276 1.1× 455 2.0× 142 0.8× 481 3.3× 25 1.0k
J.P. Vannier France 10 264 0.7× 185 0.7× 106 0.5× 190 1.1× 76 0.5× 26 659
Georg Mann Austria 13 835 2.1× 397 1.6× 571 2.5× 397 2.3× 188 1.3× 17 1.3k
E.‐W. Schwarze Germany 13 284 0.7× 124 0.5× 113 0.5× 89 0.5× 61 0.4× 37 470
Max M. van Noesel Netherlands 16 125 0.3× 291 1.1× 183 0.8× 266 1.5× 137 0.9× 44 1.0k
Kirsten Herbert Australia 14 251 0.6× 210 0.8× 54 0.2× 146 0.8× 271 1.9× 26 684
Bernadette Corront France 15 327 0.8× 266 1.0× 155 0.7× 73 0.4× 464 3.2× 28 797
Joseph M. Connors Canada 6 620 1.6× 387 1.5× 94 0.4× 251 1.4× 63 0.4× 7 764
R Pearce United Kingdom 7 373 1.0× 312 1.2× 60 0.3× 117 0.7× 243 1.7× 9 576
Magdalena Adde Sweden 5 502 1.3× 385 1.5× 72 0.3× 186 1.1× 42 0.3× 6 630

Countries citing papers authored by Elif Yakisan

Since Specialization
Citations

This map shows the geographic impact of Elif Yakisan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Yakisan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Yakisan more than expected).

Fields of papers citing papers by Elif Yakisan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif Yakisan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Yakisan. The network helps show where Elif Yakisan may publish in the future.

Co-authorship network of co-authors of Elif Yakisan

This figure shows the co-authorship network connecting the top 25 collaborators of Elif Yakisan. A scholar is included among the top collaborators of Elif Yakisan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif Yakisan. Elif Yakisan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Reiter, Alfred, Martin Schrappe, Markus Tiemann, et al.. (1999). Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.. Blood. 94(10). 3294–306. 281 indexed citations
2.
Seidemann, Kathrin, Ulrike Meyer, Petra Jansen, et al.. (1998). Impaired renal function and tumor lysis syndrome in pediatric patients with Non-Hodgkin's Lymphoma and B-ALL. Klinische Pädiatrie. 210(4). 279–284. 34 indexed citations
3.
Yakisan, Elif, E Schirg, Cornelia Zeidler, et al.. (1997). High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann’s syndrome). The Journal of Pediatrics. 131(4). 592–597. 55 indexed citations
4.
Yakisan, Elif, et al.. (1995). Absence of G‐CSF receptors and absent response to G‐CSF in childhood Burkitt's lymphoma and B‐ALL cells. British Journal of Haematology. 89(4). 771–779. 16 indexed citations
5.
Reiter, Alfred, Markus Tiemann, W.-D. Ludwig, et al.. (1994). Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 1: Klassifikation und Einteilung in strategische Therapiegruppen. Klinische Pädiatrie. 206(4). 222–233. 17 indexed citations
6.
Reiter, Alfred, Martin Schrappe, Markus Tiemann, et al.. (1994). Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.. Journal of Clinical Oncology. 12(5). 899–908. 155 indexed citations
7.
Reiter, Alfred, Martin Schrappe, Elif Yakisan, et al.. (1994). Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 3: Eine Zwischenanalyse der Therapiegruppe B-NHL/B-ALL. Klinische Pädiatrie. 206(4). 242–252. 15 indexed citations
8.
Reiter, Alfred, Martin Schrappe, Elif Yakisan, et al.. (1994). Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 2: Eine Zwischenanalyse der Therapiegruppe Non-B-NHL. Klinische Pädiatrie. 206(4). 234–241. 11 indexed citations
9.
Köenig, Alexander, Elif Yakisan, Monika Reuter, et al.. (1994). Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood. 83(10). 2836–2843. 32 indexed citations
10.
11.
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolf‐Dieter Ludwig Breakdown of academic impact, for papers by J.P. Vannier Breakdown of academic impact, for papers by Georg Mann Breakdown of academic impact, for papers by E.‐W. Schwarze Breakdown of academic impact, for papers by Max M. van Noesel Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Bernadette Corront Breakdown of academic impact, for papers by Joseph M. Connors Breakdown of academic impact, for papers by R Pearce Breakdown of academic impact, for papers by Magdalena Adde
Rankless by CCL
2026